Boyds is a pharmaceutical consultancy that works with pharma companies, biotechs, and spin-outs to support the development of new medicines for patient benefit. Boyds works from the very early stages to help ensure the creation of a target product profile and offers support all the way through the development cycle.

Their areas of speciality include orphan drug discovery and development as well as rare diseases.

TherapeutAix’s partnership with Boyds provides us and our clients with clinical and regulatory insight across the therapy areas we work in and access to creative options for early clinical development strategy and plans, particularly in rare disease areas.

Contact us

Get in touch with the team today to find out how we can guide you to help bring your molecules with promise to life efficiently and in the most cost-effective way. 

We offer an initial review of your project completely free of charge. 

We’d like to send you our company updates, invites to events and any other relevant news. By providing your details and subscribing to this list, you are giving us your consent to send you these updates.

We’ll always be mindful of how often we send our updates and you can amend your preferences at any time.

We’ll never sell or swap your data with any organisation and we’ll store your details securely, respecting your trust and privacy. Please view our privacy policy for further details.

Marketing Permissions
Please select all the ways you would like to hear from TherapeutAix:
You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.